Ensuring Compliance In The U.S. Dietary Supplement Industry: Key Regulations And The Role Of Toxicology Assessments

The U.S. dietary supplement market continues to expand rapidly, driven by increasing consumer demand for health, wellness, and preventive nutrition products. This growth comes with heightened regulatory scrutiny, requiring companies to strictly adhere to safety, labeling, and manufacturing standards.

The U.S. Food and Drug Administration play a central role in regulating dietary supplements, ensuring that products are safe, properly labeled, and manufactured under controlled conditions.

This comprehensive guide by Maven Regulatory Solutions outlines the key regulatory requirements, 2025–2026 updates, and the critical role of toxicology risk assessments in achieving compliance and market success.

Understanding Dietary Supplements Under U.S. Law

Under the Dietary Supplement Health and Education Act (DSHEA), dietary supplements are defined as products intended to supplement the diet and may include:

• Vitamins and minerals 
• Herbs and botanicals 
• Amino acids 
• Enzymes and probiotics 
• Other dietary substances 

Unlike drugs, supplements are regulated under a distinct regulatory framework, requiring manufacturers to ensure safety without pre-market FDA approval (except for NDIs).

Core FDA Regulatory Requirements for Dietary Supplements

1. Compliance with DSHEA

DSHEA establishes the foundational requirements:

• Labeling Compliance 
  • Must include a Supplement Facts panel 
  • Accurate ingredient listing and serving size 
• Ingredient Safety 
  • Use only safe and legally permissible ingredients 
• Claims Regulation 
  • Must be truthful and not misleading 
  • Cannot claim to diagnose, treat, or cure diseases 

2. Good Manufacturing Practices (GMP) Compliance

FDA GMPs (21 CFR Part 111) ensure product quality and consistency:

non-compliance may result in warning letters, recalls, or import alerts.

3. New Dietary Ingredient Notification (NDIN)

• Required if ingredients were not marketed before October 15, 1994 
• Must be submitted 75 days prior to marketing 
• Includes: 
  • Safety data 
  • Toxicological evidence 

4. Structure/Function Claims Notification

• Must notify FDA within 30 days of marketing 
• Examples: 
  • “Supports immune health” 
  • “Prevents infections” 

5. Labeling and Consumer Transparency

Mandatory label elements include:

• Product identity 
• Net quantity 
• Supplement Facts panel 
• Ingredient list 
• Manufacturer/distributor details 
• Allergen information 

6. Avoidance of Disease Claims

Prohibited claims include:

• Treating diseases 
• Preventing medical conditions 

Only structure/function claims are allowed with proper disclaimers.

7. Quality Control and Analytical Testing

Manufacturers must:

• Verify ingredient identity and potency 
• Test for: 
  • Heavy metals 
  • Pesticides 
  • Microbial contamination 

8. Serious Adverse Event Reporting (SAER)

• Mandatory reporting to FDA 
• Ensures: 
  • Consumer safety 
  • Post-market transparency 

9. State-Level Regulatory Compliance

• Additional state requirements may apply 
• Example: 
  • California Proposition 65 warnings 

10. Continuous Regulatory Monitoring

Organizations should:

• Track FDA and FTC updates 
• Engage with industry bodies like the Council for Responsible Nutrition 
• Consult regulatory experts 

Key Regulatory Updates

1. Updated “Healthy” Claim Criteria

• Revised nutrient thresholds for: 
  • Saturated fat 
  • Sodium 
  • Added sugars 

2. Ban on Red No. 3 (Erythrosine)

• Prohibited supplements 
• Compliance deadline: January 15, 2027 

3. Clarification of Dietary Supplement Definition

• FDA proposed rule to refine ingredient eligibility 

4. NIH Strategic Plan (2025–2029)

• Focus on: 
  • Public health priorities 
  • Scientific evidence gaps 

5. Updated NDI Guidance

• Improved clarity for NDIN submissions 
• Emphasis on robust toxicological evidence 

The Critical Role of Toxicology Risk Assessments

Toxicological evaluations are essential to ensure ingredient safety and regulatory compliance.

Key Objectives

• Identify toxicological hazards 
• Establish safe dosage levels 
• Assess ingredient interactions 
• Evaluate long-term exposure risks 

Core Toxicological Endpoints

Robust toxicology assessments are critical for NDIN submissions and regulatory acceptance.

Best Practices for Compliance Strategy

1. Risk-Based Regulatory Approach

• Prioritize high-risk ingredients 
• Implement preventive controls 

2. Advanced Testing and Validation

• Use validated analytical methods 
• Ensure batch-to-batch consistency 

3. Documentation and Audit Readiness

• Maintain: 
  • Technical dossiers 
  • Safety data 
  • Regulatory records 

4. Digital Compliance Systems

• Implement: 
  • eCTD-ready documentation 
  • Regulatory tracking tools 

Industry Challenges

1. Regulatory Ambiguity

• Evolving FDA interpretations 

2. Ingredient Safety Concerns

• Limited historical safety data for new ingredients 

3. Supply Chain Risks

• Adulteration and contamination 

4. Increasing Enforcement Actions

• FDA warning letters and recalls 

Strategic Advantages of Regulatory Expertise

A structured regulatory approach enables:

• Faster product approvals 
• Reduced compliance risks 
• Enhanced consumer trust 
• Global market expansion 

Conclusion

Ensuring compliance in the U.S. dietary supplement industry requires a comprehensive, science-based, and proactive regulatory strategy.

By aligning with:

• FDA and DSHEA requirements 
• GMP standards 
• Toxicological risk assessment frameworks 

companies can successfully:

• Launch compliant products 
• Maintain market access 
• Build long-term consumer confidence 

A strong focus on quality, safety, and regulatory intelligence will remain essential as the industry continues to evolve.

Frequently Asked Questions

1. What is DSHEA?

A U.S. law regulating dietary supplements.

2. What is an NDIN?

A notification required for new dietary ingredients before marketing.

3. Are dietary supplements FDA-approved?

No, but they must comply with FDA regulations.

4. What claims are allowed?

Only structure/function claims, not disease claims.

5. Why are toxicology assessments important?

They ensure ingredient safety and regulatory compliance.